Vol. 2 No. 8 (2026), Articles
Vol. 2 No. 8 (2026)

GEMOLITIK KASALLIKLAR VA YANGI TUG'ILGAN CHAQALOQLARDA Rh-KONFLIKT MEXANIZMI

Articles
Published 2026-02-27
Ashurov Sirojiddin Baxrom o'g'li
Samarqand Davlat Tibbiyot Universiteti talabasi
Ashurova Dilobar Baxrom qizi
Samarqand Davlat Tibbiyot Universiteti talabasi
Isroilova Sevinch Ilhomovna
Samarqand Davlat Tibbiyot Universiteti talabasi
Tursinbayeva Aysanem Yaqipbaevna
Samarqand Davlat Tibbiyot Universiteti talabasi
PDF

Keywords

Rh-konflikt, yangi tug'ilgan chaqaloqning gemolitik kasalligi, eritrotsitlar gemolizi, bilirubin ensefalopatiyasi, anti-Rh antitelalar, fototerapiya, almashtiruvchi qon quyish.

Abstract

Yangi tug'ilgan chaqaloqlarning gemolitik kasalligi (YTGK) ona va homila o'rtasidagi immunologik ziddiyat natijasida rivojlanib, neonatal davrning og'ir patologiyalaridan biri hisoblanadi. Mazkur maqolada Rh-konflikt mexanizmining immunologik asoslari, gemolitik jarayonning patofiziologik bosqichlari, klinik shakllari hamda diagnostika mezonlari adabiyotlar tahlili asosida yoritilgan. Shuningdek, O'zbekiston Respublikasi Sog'liqni saqlash vazirligi va Respublika ixtisoslashtirilgan gematologiya markazining ma'lumotlari asosida respublikada YTGKning uchrash darajasi, profilaktik chora-tadbirlar samaradorligi tahlil qilingan. Rh-konfliktda ona organizmida ishlab chiqarilgan anti-Rh antitelalar homila eritrotsitlarini gemolizga uchratib, anemiyaning og'ir shakllari, bilirubin ensefalopatiyasi va boshqa asoratlarga olib keladi.

PDF

References

Kasper D.L., Fauci A.S., Hauser S.L., et al. (2018). Harrison's Principles of Internal Medicine (20th ed.). McGraw-Hill Education.

2. de Haas M., Thurik F.F., Koelewijn J.M., van der Schoot C.E. (2015). Haemolytic disease of the fetus and newborn. Vox Sanguinis, 109(2), 99-113.

3. Koelewijn J.M., de Haas M., Vrijkotte T.G., et al. (2018). Risk factors for the presence of non-rhesus D red blood cell antibodies in pregnant women. BJOG, 125(7), 826-833.

4. Zipursky A., Paul V.K. (2011). The global burden of Rh disease. Archives of Disease in Childhood: Fetal and Neonatal Edition, 96(2), F84-F85.

5. World Health Organization (2021). WHO recommendations on antenatal care for a positive pregnancy experience. Geneva: WHO Press.

6. Crowther C.A., Middleton P., McBain R.D. (2013). Anti-D administration in pregnancy for preventing Rhesus alloimmunisation. Cochrane Database of Systematic Reviews, (2), CD000020.

7. O'zbekiston Respublikasi Sog'liqni saqlash vazirligi (2023). Respublika perinatal markazining 2020-2023 yillardagi statistik hisobotlari. Toshkent.

8. Alimova D.A., Karimov X.Y., Raximova G.A. (2024). Rh-manfiy homilador ayollarda anti-D immunoglobulin profilaktikasining samaradorligi. O'zbekiston tibbiyot jurnali, 1(51), 23-29.

9. Юсупова Н.А., Каримов М.Ш. (2023). Гемолитическая болезнь новорожденных в Узбекистане: клинико-эпидемиологическая характеристика. Гематология и трансфузиология, 68(3), 245-253.

10. Avent N.D., Reid M.E. (2000). The Rh blood group system: a review. Blood, 95(2), 375-387.

11. Daniels G. (2013). Human Blood Groups (3rd ed.). Wiley-Blackwell.

12. Moise K.J. Jr. (2008). Management of rhesus alloimmunization in pregnancy. Obstetrics & Gynecology, 112(1), 164-176.

13. Bowman J.M. (2003). RhD hemolytic disease of the newborn. New England Journal of Medicine, 349(6), 567-575.

14. Urbaniak S.J., Greiss M.A. (2000). RhD haemolytic disease of the fetus and the newborn. Blood Reviews, 14(1), 44-61.

15. Klein H.G., Anstee D.J. (2014). Mollison's Blood Transfusion in Clinical Medicine (12th ed.). Wiley-Blackwell.

16. Nicolaides K.H., Warenski J.C., Rodeck C.H. (1985). The relationship of fetal plasma protein concentration and hemoglobin level to the development of hydrops in rhesus isoimmunization. American Journal of Obstetrics and Gynecology, 152(3), 341-344.

17. Oepkes D., Seaward P.G., Vandenbussche F.P., et al. (2006). Doppler ultrasonography versus amniocentesis to predict fetal anemia. New England Journal of Medicine, 355(2), 156-164.

18. Kaplan M., Hammerman C. (2016). Understanding severe hyperbilirubinemia and preventing kernicterus. Clinics in Perinatology, 43(2), 249-264.

19. Watchko J.F., Tiribelli C. (2013). Bilirubin-induced neurologic damage: mechanisms and management approaches. New England Journal of Medicine, 369(21), 2021-2030.

20. Murray N.A., Roberts I.A. (2007). Haemolytic disease of the newborn. Archives of Disease in Childhood: Fetal and Neonatal Edition, 92(2), F83-F88.

21. Shapiro S.M. (2010). Chronic bilirubin encephalopathy: diagnosis and outcome. Seminars in Fetal & Neonatal Medicine, 15(3), 157-163.

22. Volpe J.J. (2018). Neurology of the Newborn (6th ed.). Elsevier.

23. O'zbekiston Respublikasi Sog'liqni saqlash vazirligi (2024). Respublika perinatal markazining 2023 yilgi faoliyat hisoboti. Toshkent.

24. Shamsiev A.M., Raximov N.M., Tursunov X.X. (2024). Yangi tug'ilgan chaqaloqlarning gemolitik kasalligida nevrologik asoratlar. Samarqand tibbiyot jurnali, 1(33), 42-48.

25. O'zbekiston Respublikasi Sog'liqni saqlash vazirligi (2021). Homiladorlar va yangi tug'ilgan chaqaloqlarda gemolitik kasalliklar profilaktikasi va davolash bo'yicha milliy klinik protokol. Toshkent.

26. Mari G., Deter R.L., Carpenter R.L., et al. (2000). Noninvasive diagnosis by Doppler ultrasonography of fetal anemia due to maternal red-cell alloimmunization. New England Journal of Medicine, 342(1), 9-14.

27. Maisels M.J., McDonagh A.F. (2008). Phototherapy for neonatal jaundice. New England Journal of Medicine, 358(9), 920-928.

28. Smits-Wintjens V.E., Walther F.J., Lopriore E. (2008). Rhesus haemolytic disease of the newborn: Postnatal management, associated morbidity and long-term outcome. Seminars in Fetal & Neonatal Medicine, 13(4), 265-271.

29. Fung Kee Fung K., Eason E., Crane J., et al. (2003). Prevention of Rh alloimmunization. Journal of Obstetrics and Gynaecology Canada, 25(9), 765-773.